Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Martini

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 30, 2020
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinomaBradley A McGregor, Aly-Khan A Lalani, Wanling Xie, et al.
The Oncologist|June 22, 2021
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsDylan J Martini, Subir Goyal, Yuan Liu, et al.
BMC Cancer|August 30, 2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapyMehmet Asim Bilen, Julie M Shabto, Dylan J Martini, et al.
The Oncologist|August 3, 2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint InhibitorsDylan J Martini, Julie M Shabto, Subir Goyal, et al.
Cancer|October 18, 2018
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapyMehmet A Bilen, Dylan J Martini, Yuan Liu, et al.
Investigational New Drugs|February 7, 2019
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trialsDylan J Martini, Yuan Liu, Julie M Shabto, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
Cancer|October 25, 2019
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trialsDylan J Martini, Meredith R Kline, Yuan Liu, et al.
The Oncologist|March 13, 2020
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with ImmunotherapyMehmet Asim Bilen, Dylan J Martini, Yuan Liu, et al.
Cancer Immunology Research|May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaRana R McKay, Dominick Bossé, Wanling Xie, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|June 30, 2020
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinomaBradley A McGregor, Aly-Khan A Lalani, Wanling Xie, et al.
The Oncologist|June 22, 2021
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsDylan J Martini, Subir Goyal, Yuan Liu, et al.
BMC Cancer|August 30, 2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapyMehmet Asim Bilen, Julie M Shabto, Dylan J Martini, et al.
The Oncologist|August 3, 2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint InhibitorsDylan J Martini, Julie M Shabto, Subir Goyal, et al.
Cancer|October 18, 2018
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapyMehmet A Bilen, Dylan J Martini, Yuan Liu, et al.
Investigational New Drugs|February 7, 2019
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trialsDylan J Martini, Yuan Liu, Julie M Shabto, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
Cancer|October 25, 2019
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trialsDylan J Martini, Meredith R Kline, Yuan Liu, et al.
The Oncologist|March 13, 2020
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with ImmunotherapyMehmet Asim Bilen, Dylan J Martini, Yuan Liu, et al.
Cancer Immunology Research|May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaRana R McKay, Dominick Bossé, Wanling Xie, et al.
Pageof 12